Atlas Trials

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Clinical trial NCT04498520 · WITHDRAWN

Trial details

NCT number
NCT04498520
Sponsor
Pamela Munster
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Hormone Receptor Positive Breast CarcinomaLocally Advanced Breast CarcinomaMetastatic Breast CarcinomaMetastatic Endometrioid AdenocarcinomaMetastatic Fallopian Tube CarcinomaMetastatic HER2 Negative Breast CarcinomaMetastatic Malignant Solid Neoplasm
Start date
2021-03-31
Primary completion
2025-06-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.